• Home
  • About Us
    • Company Profile
    • Corporate Structure
    • Milestones
  • Core Business
    • R&D and Production Base
      • Zhuhai R&D and Production Base
      • Kunming R&D and Production Base
      • Global Sales Network
    • Chinese Medicine Development
      • Chinese Medicine R&D
      • Chinese Medicinal Materials
      • Decoction Slices
    • Biomedical Technology and Products
      • Tianda Products
      • Pipeline
    • Quality Healthcare Services
  • Investor Relations
    • Corporate Information
    • Corporate Governance
    • Announcements & Circulars
    • Financial Statements
    • Shares and Details
    • Investor Calendar
    • Investor Enquiries
    • Email Alerts
    • Notices (Replacement of Lost Share Certificates)
    • Dissemination of Corporate Communications
  • Sustainability
    • Our Sustainable Development
    • ESG Report
  • Careers
    • Wort At Tianda
    • Recruitment
      • Vacancies
      • Internship Programmes
      • Trainee Programmes
  • Media Centre
    • Press Releases
    • Media Coverage
    • Contact Us
    • 繁
    • 简
繁 简
  • About Us
    • Company Profile
    • Corporate Structure
    • Milestones
  • Core Business
    • R&D and Production Base
      • Zhuhai R&D and Production Base
      • Kunming R&D and Production Base
      • Global Sales Network
    • Chinese Medicine Development
      • Chinese Medicine R&D
      • Chinese Medicinal Materials
      • Decoction Slices
    • Biomedical Technology and Products
      • Tianda Products
      • Pipeline
    • Quality Healthcare Services
  • Investor Relations
    • Corporate Information
    • Corporate Governance
    • Announcements & Circulars
    • Financial Statements
    • Shares and Details
    • Investor Calendar
    • Investor Enquiries
    • Email Alerts
    • Notices (Replacement of Lost Share Certificates)
    • Dissemination of Corporate Communications
  • Sustainability
    • Our Sustainable Development
    • ESG Report
  • Careers
    • Wort At Tianda
    • Recruitment
      • Vacancies
      • Internship Programmes
      • Trainee Programmes
  • Media Centre
    • Press Releases
    • Media Coverage
    • Contact Us

2022
  • Select Year
    1. 2025
    2. 2024
    3. 2023
    4. 2022
    5. 2021
    6. 2020
    7. 2019
    8. 2018
    9. 2017
    10. 2016
    11. 2015
    12. 2014
    13. 2013
    14. 2012
    15. 2011
    16. 2010
    17. 2009
    18. 2008
    19. 2007
  • 29.12.2022

    Announcements and Notices - [Continuing Connected Transaction] REVISION OF ANNUAL CAPS FOR EXISTING CONTINUING CONNECTED TRANSACTIONS

  • 29.12.2022

    Announcements and Notices - [Terms of Reference of Other Board Committees] TERMS OF REFERENCE OF THE RISK MANAGEMENT COMMITTEE

  • 29.12.2022

    Announcements and Notices - [Terms of Reference of the Remuneration Committee] TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE

  • 29.12.2022

    Announcements and Notices - [Terms of Reference of the Nomination Committee] TERMS OF REFERENCE OF THE NOMINATION COMMITTEE

  • 29.12.2022

    Announcements and Notices - [Terms of Reference of the Audit Committee] TERMS OF REFERENCE OF THE AUDIT COMMITTEE

  • 19.12.2022

    Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE

  • 02.12.2022

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November, 2022

  • 25.11.2022

    Announcements and Notices - [Change in Financial Year End] CHANGE OF FINANCIAL YEAR END DATE

  • 25.11.2022

    Announcements and Notices - [Interim Results] 2022 INTERIM RESULTS ANNOUNCEMENT

  • 14.11.2022

    Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING

  • 01.11.2022

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October, 2022

  • 28.10.2022

    Announcements and Notices - [Other - Miscellaneous] VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY THE CHAIRMAN AND MANAGING DIRECTOR

  • 03.10.2022

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September, 2022

  • 29.09.2022

    (Headlines Revised) Constitutional Documents Memorandum of Association and Amended and Restated Articles of Association

  • 02.09.2022

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August, 2022

  • 31.08.2022

    Announcements and Notices - [Results of AGM] POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 31 AUGUST 2022

  • 25.08.2022

    Announcements and Notices - [Dividend or Distribution (Announcement Form)] Special dividend for year ended 31 March 2022 (Updated)

  • 25.08.2022

    Announcements and Notices - [Dividend or Distribution (Announcement Form)] Final Dividend for the year ended 31 March 2022 (Updated)

  • 25.08.2022

    Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period / Change of Dividend Payment Date] CHANGE OF THE DATE OF ANNUAL GENERAL MEETING AND CHANGE OF BOOK CLOSURE PERIOD FOR THE PROPOSED FINAL DIVIDEND AND SPECIAL DIVIDEND

  • 24.08.2022

    Announcements and Notices - [Notice of AGM / Other - Miscellaneous] TYPHOON ARRANGEMENT FOR THE ANNUAL GENERAL MEETING TO BE HELD ON 25 AUGUST 2022

  • 12.08.2022

    Announcements and Notices - [Notice of AGM / Other - Miscellaneous] SUPPLEMENTAL ANNOUNCEMENT REGARDING ANNUAL GENERAL MEETING

  • 03.08.2022

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July, 2022

  • 01.08.2022

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022

  • 22.07.2022

    Proxy Forms Proxy form for use at the annual general meeting (the "AGM") of Tianda Pharmaceuticals Limited to be held on Thursday, 25 August 2022 at 10:30 a.m. (or at any adjournment thereof)

  • 22.07.2022

    Announcements and Notices - [Notice of AGM] NOTICE OF ANNUAL GENERAL MEETING

  • 22.07.2022

    Circulars - [General Mandate / Explanatory Statement for Repurchase of Shares / Re-election or Appointment of Director subject to Shareholders' Approval] PROPOSALS INVOLVING GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES; RE-ELECTION OF RETIRING DIRECTORS; DECLARATION OF FINAL DIVIDEND AND SPECIAL DIVIDEND; AND NOTICE OF ANNUAL GENERAL MEETING

  • 18.07.2022

    Announcements and Notices - [Dividend or Distribution / Closure of Books or Change of Book Closure Period / Other - Miscellaneous] CHANGE OF ADDRESS OF HONG KONG SHARE REGISTRAR AND TRANSFER OFFICE AND FINAL DIVIDEND AND SPECIAL DIVIDEND FOR THE YEAR ENDED 31 MARCH 2022 CLOSURES OF REGISTER OF MEMBERS

  • 18.07.2022

    Announcements and Notices - [Dividend or Distribution (Announcement Form)] SPECIAL DIVIDEND FOR THE YEAR ENDED 31 MARCH 2022 (UPDATED)

  • 18.07.2022

    Announcements and Notices - [Dividend or Distribution (Announcement Form)] FINAL DIVIDEND FOR THE YEAR ENDED 31 MARCH 2022 (UPDATED)

  • 04.07.2022

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022

  • 29.06.2022

    Announcements and Notices - [Dividend or Distribution (Announcement Form)] SPECIAL DIVIDEND FOR THE YEAR ENDED 31 MARCH 2022

  • 29.06.2022

    Announcements and Notices - [Final Results / Dividend or Distribution] ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 MARCH 2022

  • 29.06.2022

    Announcements and Notices - [Dividend or Distribution (Announcement Form)] FINAL DIVIDEND FOR THE YEAR ENDED 31 MARCH 2022

  • 24.06.2022

    Announcements and Notices - [Continuing Connected Transaction] CONTINUING CONNECTED TRANSACTIONS 2022 ANNUAL CAP EXCEEDED

  • 15.06.2022

    Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING

  • 01.06.2022

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022

  • 10.05.2022

    Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT-NEW R&D AND PRODUCTION BASE PUT INTO PRODUCTION

  • 03.05.2022

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April, 2022

  • 01.04.2022

    Announcements and Notices - [Continuing Connected Transaction] RENEWAL OF CONTINUING CONNECTED TRANSACTIONS

  • 01.04.2022

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022

  • 29.03.2022

    Announcements and Notices - [Major Transaction / Connected Transaction] COMPLETION OF CONNECTED AND MAJOR TRANSACTION DISPOSAL OF 100% EQUITY INTEREST OF A WHOLLY-OWNED SUBSIDIARY

  • 03.03.2022

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022

  • 09.02.2022

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January, 2022

  • 03.01.2022

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021

關注天大藥業:

  • About Us
    Company Profile Corporate Structure Milestones
  • Core Business
    R&D and Production Base Chinese Medicine Development Biomedical Technology and Products Quality Healthcare Services
  • Investor Relations
    Corporate Information Corporate Governance Announcements & Circulars Financial Statements Shares and Details Investor Calendar Investor Enquiries Email Alerts Notices (Replacement of Lost Share Certificates) Dissemination of Corporate Communications
  • Sustainability
    Our Sustainable Development ESG Reports
  • Careers
    Wort At Tianda Recruitment
  • Media Centre
    Press Releases Media Coverage Contact Us

Email AlertsPlease enter your email address

關注天大藥業:

  • Hong Kong Headquarters Level 24, CITIC Tower, No. 1 Tim Mei Avenue, Central, Hong Kong

    Tel: +852 2545 3313

    Fax: +852 2541 6558

    Email: info@tianda.com

  • China, Regional Headquarters Level 28, Block C, Tian An International Building, 3012 Renmin Road South, Shenzhen, China

    (Postal code: 518001)

    Tel: +86 755 8228 3533

    Fax: +86 755 8228 9636

  • Australia, Regional HeadquartersSuite 3.03, Level 3, Macquarie Corporate Centre, 2 Banfield Road, Macquarie Park, NSW 2113, Australia

    Tel: +61 2 9251 9001

    Fax: +61 2 9251 7688

© Tianda Pharmaceuticals Limited. All Rights Reserved.
Disclaimer | Important Notice